Predicting cerebral infarction in patients with atrial fibrillation using machine learning: The Fushimi AF registry
Authors:
- Hidehisa NishiHNHidehisa Nishi
- Naoya OishiNONaoya Oishi
- on behalf of the Fushimi AF Registry investigators.OIon behalf of the Fushimi AF Registry investigators.
- 1 December 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 42 (5) , 746-756
Abstract
The CHADS2 and CHA2DS2-VASc scores are widely used to assess ischemic risk in the patients with atrial fibrillation (AF). However, the discrimination performance of these scores is limited. Using the data from a community-based prospective cohort study, we sought to construct a machine learning-based prediction model for cerebral infarction in patients with AF, and to compare its performance with the existing scores. All consecutive patients with AF treated at 81 study institutions from March 2011 to May 2017 were enrolled (n = 4396). The whole dataset was divided into a derivation cohort (n = 1005) and validation cohort (n = 752) after excluding the patients with valvular AF and anticoagulation therapy. Using the derivation cohort dataset, a machine learning model based on gradient boosting tree algorithm (ML) was built to predict cerebral infarction. In the validation cohort, the receiver operating characteristic area under the curve of the ML model was higher than those of the existing models according to the Hanley and McNeil method: ML, 0.72 (95%CI, 0.66–0.79); CHADS2, 0.61 (95%CI, 0.53–0.69); CHA2DS2-VASc, 0.62 (95%CI, 0.54–0.70). As a conclusion, machine learning algorithm have the potential to perform better than the CHADS2 and CHA2DS2-VASc scores for predicting cerebral infarction in patients with non-valvular AF.Keywords
This publication has 34 references indexed in Scilit:
- A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk ScoreJournal of the American Heart Association, 2013
- Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF RegistryJournal of Cardiology, 2013
- Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationCirculation, 2013
- Cardiovascular Disease Risk Assessment: Insights from FraminghamGlobal Heart, 2013
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyBMJ, 2011
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial FibrillationCirculation, 2009
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summaryEuropean Heart Journal, 2006
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksCochrane Database of Systematic Reviews, 2005
- Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyCirculation, 2004
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991